Please assess the completion status of the following clinical trial:

Trial Title: Effects of a Surgical Site Injection on Pain Scores and Narcotic Use After Orthopaedic Trauma Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Lower extremity fracture including femoral neck, intertrochanteric, sub-trochanteric, and femoral shaft fracture~Exclusion Criteria:~* Pregnant women~* Treatment with Arthroplasty~* Patients who receive a peripheral nerve block~* Patients who receive intra-op or post-op ketamine~* Patients with concomitant TBI or MR~* Polytrauma patients~* Pathologic Fractures~* Patients who live greater than 10 miles from NYU or who will not be followed by an NYU provider~* Patients with a contraindication to any of the medications on the study list due to other medical problems such as renal or liver disease or due to allergy/intolerance~* Patients with prior extremity weakness resulting from stroke or other neurological condition~* Prior or current history of narcotic use~* Patients with advanced dementia~* NYUMC Students, Residents, Faculty

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Spinal Anesthesia (Type: EXPERIMENTAL): Injection of 40cc 0.25% Marcaine, 5 mg Duramorph (1 mg/cc, 5 cc total), and 30 mg of ketorolac (30 mg/cc, 1 cc total) into the periosteum, and musculature surrounding the fracture site and 0.25% Bupivacaine (Marcaine) 10 mL into the subcutaneous tissue surrounding the surgical incision.
- General Anesthesia (Type: ACTIVE_COMPARATOR): The control group will receive no injection into area surrounding the fracture site

Based on this trial design, predict the completion outcome and termination type (if applicable).